About all

Nail fungus lamisil cream: Lamisil Topical: Uses, Side Effects, Interactions, Pictures, Warnings & Dosing

Содержание

Skin and nail fungi—almost beaten

Dermatophyte infections occur often either between the outer toes or in the toenails. It is now possible to eradicate most of these, and more widespread fungal infections, with the new generation of antifungal agents. Competing claims are made for systemic terbinafine and itraconazole, and up to now it has been hard to sort out the science from the marketing. The recent paper by Evans et al1 and the systematic review in this issue by Hart et al (p 79)2 attempt to point ways through the evidence. Other problems remain in treating children and non-responders.

The conclusions reached in the systematic review by Hart et al are undermined by the limited questions asked. It is legitimate to review the evidence for topical treatments for superficial fungal infections of the skin, but common sense must be applied to the results. Use of topical drugs in the community is not necessarily the same as in a trial situation. Poor compliance is common because symptoms are rapidly relieved, whether or not there has been mycological cure. Very few applications of topical (fungicidal) terbinafine are needed to produce a cure, whereas fungistatic drugs must be applied until the infected stratum corneum is shed. One week of topical terbinafine therefore gives better cure rates than four weeks of clotrimazole.3 The implications for community cure rates, recurrence, and spreading of infection to others are obvious and the authors’ failure to consider them indicate a naivety in their cost effectiveness conclusions.

Moreover, in considering nail infections it is inappropriate to review the evidence for topical treatment in isolation from that for systemic treatment. In their discussion Hart et al correctly state that evidence on the efficacy of topical treatments for nail infections is sparse, but the summary conclusion ambiguously implies that their conclusions apply to nail as well as the skin.2 Systemic therapy, with terbinafine, is the treatment of choice for onychomycosis.1

Today’s drugs for treating superficial fungal infections are dramatically more effective than those available 20 years ago. Griseofulvin, introduced in the 1960s, is fungistatic whereas terbinafine is fungicidal even at low concentrations. Fungistatic drugs anaesthetise dermatophytes; fungicidal ones murder them. Griseofulvin therefore has to be taken until all infected tissue is lost through natural turnover—about four weeks for stratum corneum and up to 18 months for infected toenail. In contrast a fungicidal drug, such as the allylamine terbinafine, needs only to be taken for a short time until all the fungi are dead: normal appearance will slowly follow. Itraconazole is a triazole that is primarily fungistatic1 but which reaches fungicidal levels at 100 times greater concentration than for terbinafine.

Topically applied terbinafine and topical azoles rapidly penetrate the stratum corneum. Pharmacokinetic studies suggest that only a few applications of topical terbinafine will cure a dermatophyte infection.4 This is particularly useful as a high response rate may still follow low compliance.

Knowledge of the pharmacokinetics of terbinafine and itraconazole have resulted in original, but contrasting, advice over the timing of oral therapy. Both drugs penetrate nail plate rapidly and persist in nail for some time. This persistence has led Janssen to advocate a pulse therapy concept for itraconazole, in which the drug is given for only one week every month, relying on the stored reservoir of drug. Novartis has taken the more traditional approach of uninterrupted therapy for terbinafine: both suggested regimens, of equivalent cost, are for only 12 weeks for toenail disease—long enough for the drug to penetrate and the organisms to be killed. At last there is clear evidence about which regimen is most effective: Evans et al showed that terbinafine gives a 76% mycological cure rate and itraconazole a 38% cure rate in toenail onychomycosis assessed at 72 weeks after each drug had been given for 12 weeks.1

Perhaps the most contentious issue in the itraconazole-terbinafine battle has been over Candida albicans. Does candida play an important primary pathogenic role in onychomycosis, or is it usually secondary to the primary dermatophyte infection, disappearing when the dermatophyte infection is dealt with? If candida is of prime importance, itraconazole with its broad spectrum of action is indicated. However, it appears that it is only of secondary importance,5 so terbinafine is appropriate, despite its specific action. In warmer humid climates, however, candida may thrive more easily and play a more important part.

Even in the most optimistic studies, at least 15% of patients with onychomycosis are not cured. How can they be helped? If the organism is identified and known to be sensitive to the drug, presumably the drug is not reaching the organism. Roberts and Evans have suggested the concept of a “dermatophytoma,” analogous to an aspergilloma, where the space between the nail plate and the nail bed is invaded and expanded by a mass of dermatophytes, impenetrable to systemic or topical drugs. 6 Other reasons for failure may include a distorted nail plate preventing penetration, and, of course, non-compliance. There is some logic in treating such nails with a combination of oral therapy, removal of infected tissue, and topical therapy—but there is little published evidence on the effectiveness of this approach.

Children, once again, are the losers in these therapeutic advances. The complexities and expense of having drugs licensed for use in children has resulted in oral terbinafine being licensed for children in very few countries, despite a safety profile similar to that in adults7; itraconazole is similarly restricted. Griseofulvin is therefore still used in children, for skin and nail infection, despite its side effects and inferior effectiveness. The pharmaceutical industry and licensing authorities must jointly bear the blame for this continuing disadvantage to children (see p 70).

Fungal infection of the hands, body, or scalp is unsightly and uncomfortable. Although many—6.9% estimated prevalence in Ontario8—are troubled by the appearance of infected toenails and by the impact on quality of life,9 most people with localised fungal infections probably are little concerned. Now that effective therapy is available, there are pressures to educate the public about the problem, which is clearly in the interests of the pharmaceutical companies as well as the public. The risks, such as idiosyncratic liver reactions associated with oral therapy,10 need to be taken into account.

Despite the extensive work represented by this issue’s systematic review, I believe that the most effective treatment for a topical dermatophyte infection remains topical terbinafine, and for onychomycosis is oral terbinafine. Why should we recommend inferior therapy to our patients?

Treating Onychomycosis – American Family Physician

1. Scher RK,
Coppa LM.
Advances in the diagnosis and treatment of onychomycosis. Hosp Med.
1998;34:11–20….

2. Crissey JT.
Common dermatophyte infections. A simple diagnostic test and current management. Postgrad Med.
1998;103(2):191–1,197–200,205.

3. Elewski BE.
Onychomycosis: pathogenesis, diagnosis, and management. Clin Microbiol Rev.
1998;11:415–29.

4. Scher RK.
Onychomycosis: a significant medical disorder. J Am Acad Dermatol.
1996;35(3 pt 2):S2–5.

5. Evans EG.
Causative pathogens in onychomycosis and the possibility of treatment resistance: a review. J Am Acad Dermatol.
1998;38(5 pt 3):S32–56.

6. Lesher JL.
Recent developments in antifungal therapy. Dermatol Clin.
1996;14(1):163–9[Published erratum appears in Dermatol Clin 1996;14(4):xii].

7. Ciclopirox (Penlac) nail lacquer for onychomycosis. Med Lett Drugs Ther.
2000;42(1080):51–2.

8. Trepanier EF,
Amsden GW.
Current issues in onychomycosis. Ann Pharmacother.
1998;32:204–13.

9. Gupta AK,
Daniel CR 3d.
Factors that may affect the response of onychomycosis to oral antifungal therapy. Australas J Dermatol.
1998;39:222–4.

10. Rezabek GH,
Friedman AD.
Superficial fungal infections of the skin. Diagnosis and current treatment recommendations. Drugs.
1992;43:674–82.

11. Hay RJ.
Onychomycosis. Agents of choice. Dermatol Clin.
1993;11(1):161–9.

12. Elewski BE,
Hay RJ.
Update on the management of onychomycosis: highlights of the Third Annual International Summit on Cutaneous Antifungal Therapy. Clin Infect Dis.
1996;23:305–13.

13. Gupta AK,
Scher RK,
Rich P.
Fluconazole for the treatment of onychomycosis: an update. Int J Dermatol.
1998;37:815–20.

14. Roberts DT.
Oral terbinafine (Lamisil) in the treatment of fungal infections of the skin and nails. Dermatology.
1997;194(suppl 1):37–9.

15. Katz HI,
Gupta AK.
Oral antifungal drug interactions. Dermatol Clin.
1997;15(3):535–44.

16. Physicians’ desk reference. 54th ed. Montvale, N.J.: Medical Economics, 2000.

17. Sporanox product information update. Titusville, N.J.: Janssen Pharmaceuticals, December 10, 1999.

18. Del Rosso JQ,
Gupta AK.
Oral antifungal agents: recognition and management of adverse reactions. Todays Ther Trends.
1997;15(2):75–84.

19. Hofmann H,
Brautigam M,
Weidinger G,
Zaun H.
Treatment of toenail onychomycosis. A randomized, double-blind study with terbinafine and griseofulvin. LAGOS II Study Group. Arch Dermatol.
1995;131:919–22.

20. Goodfield MJ,
Andrew L,
Evans EG.
Short term treatment of dermatophyte onychomycosis with terbinafine. BMJ.
1992;304:1151–4.

21. Gupta AK,
Scher RK,
De Doncker P.
Current management of onychomycosis. An overview. Dermatol Clin.
1997;15(1):121–35.

22. Gupta AK,
De Doncker P,
Scher RK,
Haneke E,
Daniel CR 3d,
Andre J,

et al.
Itraconazole for the treatment of onychomycosis. Int J Dermatol.
1998;37:303–8.

23. De Doncker PD,
Gupta AK,
Marynissen G,
Stoffels P,
Heremans A.
Itraconazole pulse therapy for onychomycosis and dermatomycosis: an overview. J Am Acad Dermatol.
1997;37:969–74.

24. Havu V,
Brandt D,
Heikkila H,
Hollmen A,
Oksman R,
Rantanen T,

et al.
A double-blind, randomised study comparing itraconazole pulse therapy with continuous dosing for the treatment of toe-nail onychomycosis. Br J Dermatol.
1997;136:230–4.

25. De Doncker P,
Decroix J,
Pierard GE,
Roelant D,
Woestenborghs R,
Jacqmin P,

et al.
Antifungal pulse therapy for onychomycosis. A pharmacokinetic and pharmacodynamic investigation of monthly cycles of 1-week pulse therapy with itraconazole. Arch Dermatol.
1996;132:34–41.

26. Scher RK.
Onychomycosis: therapeutic update. J Am Acad Dermatol.
1999;40(6 pt 2):S21–6.

27. Scher RK,
Breneman D,
Rich P,
Savin RC,
Feingold DS,
Konnikov N,

et al.
Once-weekly fluconazole (150, 300, or 450 mg) in the treatment of distal subungual onychomycosis of the toenail. J Am Acad Dermatol.
1998;38(6 pt 2):S77–86.

28. Ling MR,
Swinyer LJ,
Jarratt MT,
Falo L,
Monroe EW,
Tharp M,

et al.
Once-weekly fluconazole (450 mg) for 4, 6, or 9 months of treatment for distal subungual onychomycosis of the toenail. J Am Acad Dermatol.
1998;38(6 pt 2):S95–102.

29. Drake L,
Babel D,
Stewart DM,
Rich P,
Ling MR,
Breneman D,

et al.
Once-weekly fluconazole (150, 300, or 450 mg) in the treatment of distal subungual onychomycosis of the fingernail. J Am Acad Dermatol.
1998;38(6 pt 2):S87–94.

30. De Backer M,
De Vroey C,
Lessaffre E,
Scheys I,
De Keyser P.
Twelve weeks of continuous oral therapy for toenail onychomycosis caused by dermatophytes: a double-blind comparative trial of terbinafine 250 mg/day versus itraconazole 200 mg/day. J Am Acad Dermatol.
1998;38(5 pt 3):S57–63.

31. Brautigam M,
Nolting S,
Schopf RE,
Weidinger G.
Randomised double blind comparison of terbinafine and itraconazole for treatment of toenail tinea infection. Seventh Lamisil German Onychomycosis Study Group. BMJ.
1995;311:919–22 [Published erratum appears in BMJ 1995;311:1350].

32. De Backer M,
De Keyser P,
De Vroey E,
Lesaffre E.
A 12-week treatment for dermatophyte toe onychomycosis: terbinafine 250 mg/day vs. itraconazole 200 mg/day—a double-blind comparative trial. Br J Dermatol.
134(suppl 46):16–17.

33. Evans EG,
Sigurgeirsson B.
Double blind, randomised study of continuous terbinafine compared with intermittent itraconazole in treatment of toenail onychomycosis. The LION Study Group. BMJ.
1999;318:1031–5.

34. Bootman JL.
Cost-effectiveness of two new treatments for onychomycosis: an analysis of two comparative clinical trials. J Am Acad Dermatol.
1998;38(5 pt 3):S69–72.

35. Roberts DT,
Evans EG.
Subungual dermatophytoma complicating dermatophyte onychomycosis [Letter]. Br J Dermatol.
1998;138:189–90.

36. Baran R,
Hay RJ.
Partial surgical avulsion of the nail in onychomycosis. Clin Exp Dermatol.
1985;10:413–8.

37. Zaias N,
Tosti A,
Rebell G,
Morelli R,
Bardazzi F,
Bieley H,

et al.
Autosomal dominant pattern of distal subungual onychomycosis caused byTrichophyton rubrum. J Am Acad Dermatol.
1996;34(2 pt 1):302–4.

38. Elewski BE.
Cutaneous mycoses in children. Br J Dermatol.
1996;134(suppl 46):7–11.

39. Krafchik B,
Pelletier J.
The use of oral terbinafine (Lamisil) in children. Dermatology.
1997;194(suppl 1):43–4.

Efficacy, Safety, and Tolerability of Topical Terbinafine in Patients With Mild to Moderate Toenail Fungus of the Big Toenail – Full Text View

Dr. Boni Elewski
Birmingham, Alabama, United States, 35233
Dr. Stacy Smith
San Diego, California, United States, 92123
Dr. James Swinehart
Denver, Colorado, United States, 80210
Dr. David G. Armstrong
North Chicago, Illinois, United States, 60064
Dr. Kevin Terry
Lutherville, Maryland, United States, 21093
Dr. Anthony Puopolo
Milford, Massachusetts, United States, 01757
Dr. John Fenyk
Chaska, Minnesota, United States, 55318
Dr. Joel Schlessinger
Omaha, Nebraska, United States, 68144
Dr. AnneMarie Uliasz
New York, New York, United States, 10029
Dr. Willard Niemi
Raleigh, North Carolina, United States, 27615
Dr. Diane Baker
Lake Oswego, Oregon, United States, 97035
Dr. John Barnes
Portland, Oregon, United States, 97205
Dr. Harry Penny
Altoona, Pennsylvania, United States, 16602
Dr. Lawrence Parish
Philadelphia, Pennsylvania, United States, 19103
Dr. Cynthia Strout
Mt. Pleasant, South Carolina, United States, 29464
Dr. Teresa Coats
Austin, Texas, United States, 78705
Dr. Scott J. Ashton
Dallas, Texas, United States, 75243
Dr. Amit Pandya
Dallas, Texas, United States, 75390-8802
Dr. Lawrence Harkless
San Antonio, Texas, United States, 78207
Dr. Robert Shouey
Harrisonburg, Virginia, United States, 22801
Novartis Investigative Site
Various cities, Canada
Novartis Investigative Site
Various cities, Iceland

Lamisil AT Antifungal Cream, 1 oz (30 g)

Lamisil AT Antifungal Cream, 1 oz (30 g) | Rite Aid

The store will not work correctly in the case when cookies are disabled.

JavaScript seems to be disabled in your browser.

For the best experience on our site, be sure to turn on Javascript in your browser.

You have signed up successfully

{{#if error}}

{{/if}}
{{success}}

{{/in}}

{{/in}}

{{/in}}

{{#genertatePrescriptionText pharmacyDetails.count}}
Your {{count}} {{prescriptions}} {{status}}
{{/genertatePrescriptionText}}

login
Please log in to your Pharmacy account

{{/in}}

 Add Pharmacy Management

{{/in}}

{{/in}}

{{/in}}

{{/in}}

{{/in}}

Allergy Relief Products.  Shop Now

{{/in}}

{{/in}}

{{/in}}

{{/in}}

From the Manufacturer

PRODUCT DETAILS

Item No. 0362904

LamisilAT Prescription Strength Athletes Foot Antifungal Cream for athletes foot treatment relieves symptoms and kills the fungus that causes athletes foot. Featuring the active ingredient terbinafine hydrochloride 1%, this full prescription strength Lamisil antifungal cream is clinically proven to cure most athletes foot between the toes, and it’s also an effective jock itch cream and ringworm treatment. Lamisil terbinafine hydrochloride antifungal cream relieves uncomfortable symptoms, such as itching, burning, cracking and scaling. To use, begin by washing and drying the infected area. Then, simply apply a thin layer of cream to the affected skin and adjacent areas. Get proven relief from LamisilAT antifungal foot cream.

  • One 1-ounce tube of LamisilAT Prescription Strength Athletes Foot Antifungal Cream, Athletes Foot Treatment for Burning, Cracking and Itch Relief
  • Full prescription strength Lamisil cream that’s clinically proven to cure most athletes foot between the toes
  • Effective jock itch treatment and ringworm cream that relieves itching, burning, cracking and scaling
  • Active ingredient terbinafine hydrochloride 1% delivers effective foot fungus treatment
  • LamisilAT treats most athlete’s foot 4 times faster than a leading brand containing azole, with 3 to 4 weeks of treatments, killing the fungus within 7 days when you treat according to usage directions

Over-the-counter anti-fungal medication is now available for FSA and HSA reimbursement without a prescription. For any questions you may have regarding FSAs or HSAs, please browse our FAQ.

MORE INFORMATION

More Information
Product Name Lamisil AT Antifungal Cream – 1 oz
Package Count 1
Container Type box
Form Cream
Color Specs Tab Other
Skin Type Combination
Country of Manufacture United States
Best For Itch Relief
Prop 65 No

HOW TO USE

Adults and children 12 years and over Use the tip of the cap to break the seal and open the tube. Wash the affected skin with soap and water and dry completely before applying. For athletes foot Wear well-fitting, ventilated shoes. Change shoes and socks at least once daily. Between the toes only Apply twice a day (morning and night) for 1 week or as directed by a doctor. On the bottom or sides of the foot Apply twice a day (morning and night) for 2 weeks or as directed by a doctor. For jock itch and ringworm Apply once a day (morning or night) for 1 week or as directed by a doctor. Wash hands after each use. Children under 12 years Ask a doctor. Store at controlled room temperature 20-25C (68-77F).

INGREDIENTS

Active Ingredients: Terbinafine hydrochloride 1% – Antifungal; Inactive Ingredients: Benzyl alcohol, cetyl alcohol, cetyl palmitate, isopropyl myristate, polysorbate 60, purified water, sodium hydroxide, sorbitan monostearate, stearyl alcohol.

SAFETY

For external use only. Do not use on nails or scalp. In or near the mouth or eyes. For vaginal yeast infections. When using this product do not get into eyes. If eye contact occurs, rinse thoroughly with water. Stop use and ask a doctor if too much irritation occurs or gets worse. Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

Reviews

Close

Just a moment while we apply your discounts.

=”evenodd”>!

Can Lamisil cream be used for nail fungus? – Kitchen

If you have a fungal nail infection (fungus inside and under the nail) with discolouration of the nails and changes in nail texture (thick or flaky), you should consult your doctor because Lamisil AT 1% Cream is not appropriate for this type of infection.

Does lamisil cream work for toenail fungus?

Over-the-Counter Treatments If you have mild onychomycosis restricted to the ends of the nail, OTC products like Lamisil (terbinafine) cream may provide relief in conjunction with regular debridement and consistent use over four to six months. The cost of generic Lamisil cream is around $12 for a 0.46-ounce tube.

Can I use Lamisil cream on my fingernails?

Do not apply this medication on the scalp or nails unless otherwise directed by your doctor. The dosage and length of treatment depends on the type of infection being treated. Do not apply more often or use longer than directed. This may increase the risk of side effects.

Will antifungal cream kill toenail fungus?

Topical treatments like antifungal creams and medicated nail lacquers are among the most effective treatment options for toenail fungus. Laser treatment or the surgical removal of the toenail may be necessary in more severe cases of toenail fungus.

What is the best cream for fungal nail infection?

Terbinafine Hydrochloride AntiFungal Cream works to address a variety of infections, including toenail fungus. The prescription-strength cream is recommended by Dr. Lipner to treat athlete’s foot before it spreads to the toenails. It works by killing the fungus and preventing its growth.

How do you use Lamisil cream for toenail fungus?

Apply just enough cream to form a thin layer on the affected skin and surrounding areas. Rub in gently. When used between the toes, buttocks or on the groin, the treated area may be covered with a light, fresh gauze strip, especially at night.

How long does it take for Lamisil cream to cure toenail fungus?

In studies, their cure rate averaged around 35%. Oral medications. Itraconazole (Sporanox) and terbinafine (Lamisil) eliminated the fungus in 10 months for 55% to 70% of people in the studies required for FDA approval, but for 15% to 20% of users, the fungus returned within a few months.

What kills toenail fungus instantly?

Hydrogen peroxide. Hydrogen peroxide can kill fungus that grows on toenails. You can directly wipe hydrogen peroxide on your infected toes or toenails with a clean cloth or cotton swab. Hydrogen peroxide can also be used in a foot soak.

Can you file nail fungus away?

With that in mind, I generally encourage healthy adult patients with mild toenail fungus to not treat it or to treat it just using topical measures. For example, you can buff the nail down with a file to keep it thin, so the fungus has less of a home to live in. You should also keep the nail trimmed.

Does anything really cure toenail fungus?

Taking antifungal pills for two months can cure an infection under the fingernails. Usually three months of treatment cures a toenail fungal infection. Antifungal pills, however, can cause side effects. Your dermatologist will watch you closely.

Should I cut off my fungus toenail?

If you do have a toenail fungus, your doctor will likely recommend one or more of the following treatment options: Trimming the Toenail Trimming the toenail is usually combined with medication, but having a podiatrist periodically trim the nail down is helpful and allows the medication to work better, says Sundling.

How do I know if my toenail fungus is dying?

Top 5 signs your toenail fungus has gone nuclear

  1. Nail color changes. If your nail turns white and chalky or yellow, it’s not a good sign.
  2. Nail position changes. If your nail starts to curl downward or upward, it’s time to be concerned.
  3. Nail texture changes.
  4. Nail smell changes.
  5. Nail sensation changes.

What does lamisil treat?

Lamisil Tablets is a prescription antifungal medicine used to treat fungal infections of the fingernails and toenails (onychomycosis). Your doctor should do tests to check you for fungal infection of your nails before you start Lamisil Tablets.

What happens if you leave toenail fungus untreated?

If you let a nail fungus infection go for too long, several problems emerge. The infected nail can become misshapen and increasingly separated from your nail bed. Itching and pain are unpleasant side effects; if they’re too severe, you can have trouble wearing shoes or walking.

How do you get rid of toenail fungus in 10 minutes?

How to use it. A person can try putting baking soda inside their socks and shoes to soak up moisture. People can also apply a paste of baking soda and water directly to the affected nail and let it sit for at least 10 minutes before rinsing. Repeat this several times a day until the fungus clears.

Lamisil – Uses, Side Effects, Interactions

How does this medication work? What will it do for me?

Terbinafine belongs to the class of medications called antifungals. It is used to treat certain types of fungal infections of the skin and nails.

This medication may be available under multiple brand names and/or in several different forms. Any specific brand name of this medication may not be available in all of the forms or approved for all of the conditions discussed here. As well, some forms of this medication may not be used for all of the conditions discussed here.

Your doctor may have suggested this medication for conditions other than those listed in these drug information articles. If you have not discussed this with your doctor or are not sure why you are taking this medication, speak to your doctor. Do not stop taking this medication without consulting your doctor.

Do not give this medication to anyone else, even if they have the same symptoms as you do. It can be harmful for people to take this medication if their doctor has not prescribed it.

Sponsored Health Tool

What form(s) does this medication come in?

Tablet

Each round, whitish-yellow, uncoated tablet, scored on one side and embossed “Lamisil 250”, contains 250 mg of terbinafine. Nonmedicinal ingredients: cellulose microcrystalline, magnesium stearate, hydroxypropyl methylcellulose, silica, colloidal anhydrous, and sodium carboxymethyl starch.

Cream

Each gram of white, smooth, glossy cream contains 10 mg of terbinafine. Nonmedicinal ingredients: benzyl alcohol, cetyl alcohol, cetyl palmitate, isopropyl myristate, polysorbate 60, purified water, sodium hydroxide, sorbitan monostearate, and stearyl alcohol.

Spray

Each gram of clear solution contains 10 mg of terbinafine. Nonmedicinal ingredients: cetomacrogol 1,000, ethanol, propylene glycol, and water.

How should I use this medication?

Tablets: The recommended adult dose is 250 mg once daily. The tablet should be taken with water and may be taken with food or on an empty stomach. Try to take the medication at the same time each day. The length of treatment depends on the condition being treated and the severity of the infection.

Cream: Use the cream once or twice daily as directed by your doctor. Before applying, clean and thoroughly dry the affected areas. Apply the cream to the affected skin and surrounding area in a thin layer and rub it in lightly. The length of treatment depends on the condition being treated and the severity of the infection. If necessary, the area being treated may be covered with a strip of gauze to protect the area from irritation.

Spray: Use the spray once or twice daily as directed by your doctor. Before applying, clean and thoroughly dry the affected areas. Spray enough of the solution to thoroughly wet the treatment area and to cover the affected skin and surrounding area. The length of treatment depends on the condition being treated and the severity of the infection.

Many things can affect the dose of medication that a person needs, such as body weight, other medical conditions, and other medications. If your doctor has recommended a dose different from the ones given here, do not change the way that you are taking the medication without consulting your doctor.

It is important to take this medication exactly as prescribed. Use the medication for the prescribed length of time even if the infection clears up, to prevent it from coming back. If you miss a dose, use it as soon as you remember. If it is the following day before you remember your next dose, skip the missed dose and resume your usual dosing schedule. Do not use a double dose to make up for a missed one. If you are not sure what to do after missing a dose, contact your doctor or pharmacist for advice.

Store this medication at room temperature, protect it from light and moisture, and keep it out of the reach of children.

Do not dispose of medications in wastewater (e.g. down the sink or in the toilet) or in household garbage. Ask your pharmacist how to dispose of medications that are no longer needed or have expired.

Who should NOT take this medication?

Do not take this medication if you:

  • are allergic to terbinafine or any ingredients of the medication
  • have long-term or active liver disease

Sponsored Health Tool

What side effects are possible with this medication?

Many medications can cause side effects. A side effect is an unwanted response to a medication when it is taken in normal doses. Side effects can be mild or severe, temporary or permanent.

The side effects listed below are not experienced by everyone who takes this medication. If you are concerned about side effects, discuss the risks and benefits of this medication with your doctor.

The following side effects have been reported by at least 1% of people taking this medication. Many of these side effects can be managed, and some may go away on their own over time.

Contact your doctor if you experience these side effects and they are severe or bothersome. Your pharmacist may be able to advise you on managing side effects.

Tablets:

  • bloating or feeling of fullness in the stomach
  • diarrhea
  • headache
  • heartburn
  • increased sensitivity to the sun
  • loss of appetite
  • nausea
  • stomach pain (mild)

Cream, spray:

  • burning
  • dryness
  • flaking or peeling skin
  • itching
  • other signs of skin irritation not present before use of this medication
  • peeling
  • rash
  • redness
  • scabs
  • skin discoloration
  • skin lesions
  • stinging
  • tingling

Although most of the side effects listed below don’t happen very often, they could lead to serious problems if you do not seek medical attention.

Check with your doctor as soon as possible if any of the following side effects occur:

Tablets:

  • aching joints and muscles
  • changes in sense of taste lasting for several days
  • change of taste or loss of taste
  • fever
  • hearing changes
  • signs of anemia (low red blood cells; e.g., dizziness,  pale skin, unusual tiredness or weakness, shortness of breath)
  • signs of depression (e.g., poor concentration, changes in weight, changes in sleep, decreased interest in activities, thoughts of suicide)
  • signs of muscle breakdown (e.g., discoloured urine, unexpected muscle pain, aches)
  • skin rash or itching
  • symptoms of blood disorders (such as sore throat, fever, chills, mouth sores, or unusual bleeding or bruising)
  • symptoms of liver problems (such as unusual fatigue, yellow eyes or skin, abdominal pain, dark urine, pale stools, itching, or loss of appetite)
  • vision changes
  • weight loss

Stop taking the medication and seek immediate medical attention if any of the following occur:

  • signs of pancreatitis (e. g., abdominal pain on the upper left side, back pain, nausea, fever, chills, rapid heartbeat, swollen abdomen)
  • symptoms of a serious allergic reaction (such as hives, difficulty breathing, or swelling of the face or throat)
  • symptoms of a serious skin rash (such as redness, blistering, peeling, or loosening of skin)

Some people may experience side effects other than those listed. Check with your doctor if you notice any symptom that worries you while you are taking this medication.

Sponsored Health Tool

Are there any other precautions or warnings for this medication?

Before you begin using a medication, be sure to inform your doctor of any medical conditions or allergies you may have, any medications you are taking, whether you are pregnant or breast-feeding, and any other significant facts about your health. These factors may affect how you should use this medication.

Blood counts: This medication may decrease the number of neutrophils (a type of white blood cell that helps fight infection), red blood cells (which carry oxygen), and platelets (which help your blood to clot). Your doctor will do blood tests to monitor this. If you notice any signs of infection (e.g., fever, chills, or sore throat) or unusual bleeding or bruising, contact your doctor immediately.

Depression: Rarely, this medication has been reported to cause mood swings and symptoms of depression. If you have depression or a history of depression or anxiety, discuss with your doctor how this medication may affect your medical condition, how your medical condition may affect the dosing and effectiveness of this medication, and whether any special monitoring is needed. If you experience symptoms of depression such as poor concentration, changes in weight, changes in sleep, decreased interest in activities, or notice them in a family member who is taking this medication contact your doctor as soon as possible.

External use only: Terbinafine cream and spray are for external use only. Avoid contact with the eyes. Do not use the spray on the face. In case of accidental contact with the eyes, rinse eyes thoroughly with running water and consult a doctor if any symptoms persist. In case of inhalation, contact a doctor if any symptoms develop and persist. Topical forms of terbinafine are not effective for treating fungal infections of the nails.

Kidney function: The safety and effectiveness of using terbinafine have not been determined for people with decreased kidney function. The kidneys are partially responsible for removing terbinafine from the body. Decreased kidney function may cause terbinafine to build up in the body causing side effects. If you have decreased kidney function, discuss with your doctor how this medication may affect your medical condition, how your medical condition may affect the dosing and effectiveness of this medication, and whether any special monitoring is needed.

Liver function: Terbinafine tablets are not recommended for people with chronic (long-term) or active liver disease. Decreased liver function can cause terbinafine to build up in the body, causing side effects including further liver damage. Your doctor may order liver function tests before you start and while you are taking terbinafine tablets. During treatment with terbinafine, report to your doctor any signs or symptoms of liver problems including unusual fatigue, loss of appetite, yellowing of skin or eyes, abdominal pain, nausea and vomiting, dark urine, pale stools, or itching.

Lupus erythematosus: Occasionally, people taking terbinafine report a flare-up of systemic lupus erythematosus (SLE). If you have SLE, discuss with your doctor how this medication may affect your medical condition, how your medical condition may affect the dosing and effectiveness of this medication, and whether any special monitoring is needed.

Sensory disturbances: People taking terbinafine occasionally experience changes in how they sense things. Vision changes, difficulty hearing, a decreased sense of touch, change in the sense of taste or loss of smell have all been reported. If you notice changes while you are taking this medication, contact your doctor.

Pregnancy: This medication should not be used during pregnancy unless the benefits outweigh the risks. If you become pregnant while taking this medication, contact your doctor immediately.

Breast-feeding: This medication passes into breast milk. If you are a breast-feeding mother and are taking terbinafine, it may affect your baby. Women taking terbinafine tablets should not breast-feed. If you are using the cream or spray, talk to your doctor about whether you should continue breast-feeding.

Children: The safety and effectiveness of using this medication have not been established for children.

What other drugs could interact with this medication?

There may be an interaction between terbinafine and any of the following:

  • amiodarone
  • antipsychotic medications (e. g., chlorpromazine, clozapine, haloperidol, olanzepine, quetiapine, risperidone)
  • atomoxetine
  • azole antifungals (e.g., fluconazole, itraconazole, ketoconazole)
  • beta-adrenergic blockers (e.g., atenolol, propranolol, sotalol)
  • birth control pills
  • caffeine and products that contain caffeine
  • captopril
  • carbamazepine
  • carvedilol
  • chloroquine
  • chlorpheniramine
  • cimetidine
  • codeine
  • cyclosporine
  • dextromethorphan
  • doxepin
  • doxorubicin
  • fesoterodine
  • flecainide
  • MAO inhibitors type B (e.g., maprotiline, selegiline)
  • mercaptopurine
  • methamphetamine
  • mexiletine
  • mirtazapine
  • nefazodone
  • oxycodone
  • phenobarbital
  • phenytoin
  • pimozide
  • primaquine
  • primidone
  • procainamide
  • propafenone
  • rifabutin
  • rifampin
  • Saccharomyces boulardii
  • selective serotonin reuptake inhibitors (SSRIs; e. g., citalopram, fluoxetine, paroxetine, sertraline)
  • tamoxifen
  • tamsulosin
  • tetrabenazine
  • theophylline
  • tolbutamide
  • tolterodine
  • tramadol
  • triazolam
  • tricyclic antidepressants (e.g., amitriptyline, desipramine)
  • venlafaxine
  • warfarin

If you are taking any of these medications, speak with your doctor or pharmacist. Depending on your specific circumstances, your doctor may want you to:

  • stop taking one of the medications,
  • change one of the medications to another,
  • change how you are taking one or both of the medications, or
  • leave everything as is.

An interaction between two medications does not always mean that you must stop taking one of them. Speak to your doctor about how any drug interactions are being managed or should be managed.

Medications other than those listed above may interact with this medication. Tell your doctor or prescriber about all prescription, over-the-counter (non-prescription), and herbal medications you are taking. Also tell them about any supplements you take. Since caffeine, alcohol, the nicotine from cigarettes, or street drugs can affect the action of many medications, you should let your prescriber know if you use them.

All material copyright MediResource Inc. 1996 – 2021. Terms and conditions of use. The contents herein are for informational purposes only. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Source: www.medbroadcast.com/drug/getdrug/Lamisil

Lamisil (terbinafine) dosing, indications, interactions, adverse effects, and more

  • abametapir

    Monitor Closely (1)abametapir will increase the level or effect of terbinafine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.

  • amiodarone

    Monitor Closely (2)amiodarone will increase the level or effect of terbinafine by affecting hepatic enzyme CYP1A2 metabolism. Use Caution/Monitor.

    amiodarone will increase the level or effect of terbinafine by affecting hepatic enzyme CYP2C9/10 metabolism. Use Caution/Monitor.

  • amitriptyline

    Monitor Closely (1)terbinafine will increase the level or effect of amitriptyline by affecting hepatic enzyme CYP2D6 metabolism. Modify Therapy/Monitor Closely. Assess need to reduce dose of CYP2D6-metabolized drug.

  • amobarbital

    Monitor Closely (1)amobarbital will decrease the level or effect of terbinafine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.

  • amoxapine

    Monitor Closely (1)terbinafine will increase the level or effect of amoxapine by affecting hepatic enzyme CYP2D6 metabolism. Modify Therapy/Monitor Closely. Assess need to reduce dose of CYP2D6-metabolized drug.

  • apalutamide

    Monitor Closely (1)apalutamide will decrease the level or effect of terbinafine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.

  • aripiprazole

    Monitor Closely (1)terbinafine will increase the level or effect of aripiprazole by affecting hepatic enzyme CYP2D6 metabolism. Modify Therapy/Monitor Closely. Assess need to reduce dose of CYP2D6-metabolized drug.

  • atazanavir

    Monitor Closely (1)atazanavir will increase the level or effect of terbinafine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.

  • atogepant

    Monitor Closely (1)terbinafine will decrease the level or effect of atogepant by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.

  • atomoxetine

    Monitor Closely (1)terbinafine will increase the level or effect of atomoxetine by affecting hepatic enzyme CYP2D6 metabolism. Modify Therapy/Monitor Closely. Assess need to reduce dose of CYP2D6-metabolized drug.

  • bosentan

    Monitor Closely (2)bosentan will decrease the level or effect of terbinafine by affecting hepatic enzyme CYP2C9/10 metabolism. Use Caution/Monitor.

    bosentan will decrease the level or effect of terbinafine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.

  • brexpiprazole

    Monitor Closely (1)terbinafine will increase the level or effect of brexpiprazole by affecting hepatic enzyme CYP2D6 metabolism. Modify Therapy/Monitor Closely. Assess need to reduce dose of CYP2D6-metabolized drug.

  • butabarbital

    Monitor Closely (1)butabarbital will decrease the level or effect of terbinafine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.

  • butalbital

    Monitor Closely (1)butalbital will decrease the level or effect of terbinafine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.

  • capecitabine

    Monitor Closely (1)capecitabine will increase the level or effect of terbinafine by affecting hepatic enzyme CYP2C9/10 metabolism. Use Caution/Monitor.

  • captopril

    Monitor Closely (1)terbinafine will increase the level or effect of captopril by affecting hepatic enzyme CYP2D6 metabolism. Modify Therapy/Monitor Closely. Assess need to reduce dose of CYP2D6-metabolized drug.

  • carbamazepine

    Monitor Closely (2)carbamazepine will decrease the level or effect of terbinafine by affecting hepatic enzyme CYP2C9/10 metabolism. Use Caution/Monitor.

    carbamazepine will decrease the level or effect of terbinafine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.

  • carvedilol

    Monitor Closely (1)terbinafine will increase the level or effect of carvedilol by affecting hepatic enzyme CYP2D6 metabolism. Modify Therapy/Monitor Closely. Assess need to reduce dose of CYP2D6-metabolized drug.

  • chloramphenicol

    Monitor Closely (1)chloramphenicol will increase the level or effect of terbinafine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.

  • chlordiazepoxide

    Monitor Closely (1)terbinafine will increase the level or effect of chlordiazepoxide by affecting hepatic enzyme CYP2D6 metabolism. Modify Therapy/Monitor Closely. Assess need to reduce dose of CYP2D6-metabolized drug.

  • chloroquine

    Monitor Closely (1)terbinafine will increase the level or effect of chloroquine by affecting hepatic enzyme CYP2D6 metabolism. Modify Therapy/Monitor Closely. Assess need to reduce dose of CYP2D6-metabolized drug.

  • chlorpromazine

    Monitor Closely (1)terbinafine will increase the level or effect of chlorpromazine by affecting hepatic enzyme CYP2D6 metabolism. Modify Therapy/Monitor Closely. Assess need to reduce dose of CYP2D6-metabolized drug.

  • cinacalcet

    Monitor Closely (1)terbinafine will increase the level or effect of cinacalcet by affecting hepatic enzyme CYP2D6 metabolism. Modify Therapy/Monitor Closely. Assess need to reduce dose of CYP2D6-metabolized drug.

  • ciprofloxacin

    Monitor Closely (1)ciprofloxacin will increase the level or effect of terbinafine by affecting hepatic enzyme CYP1A2 metabolism. Use Caution/Monitor.

  • citalopram

    Monitor Closely (1)terbinafine will increase the level or effect of citalopram by affecting hepatic enzyme CYP2D6 metabolism. Modify Therapy/Monitor Closely. Assess need to reduce dose of CYP2D6-metabolized drug.

  • clarithromycin

    Monitor Closely (1)clarithromycin will increase the level or effect of terbinafine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.

  • clomipramine

    Monitor Closely (1)terbinafine will increase the level or effect of clomipramine by affecting hepatic enzyme CYP2D6 metabolism. Modify Therapy/Monitor Closely. Assess need to reduce dose of CYP2D6-metabolized drug.

  • cobicistat

    Monitor Closely (1)cobicistat will increase the level or effect of terbinafine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.

  • codeine

    Monitor Closely (1)terbinafine will increase the level or effect of codeine by affecting hepatic enzyme CYP2D6 metabolism. Modify Therapy/Monitor Closely. Assess need to reduce dose of CYP2D6-metabolized drug.

  • conivaptan

    Monitor Closely (1)conivaptan will increase the level or effect of terbinafine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.

  • dabrafenib

    Monitor Closely (1)dabrafenib will decrease the level or effect of terbinafine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.

  • darunavir

    Monitor Closely (1)darunavir will increase the level or effect of terbinafine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.

  • delavirdine

    Monitor Closely (1)delavirdine will increase the level or effect of terbinafine by affecting hepatic enzyme CYP2C9/10 metabolism. Use Caution/Monitor.

  • desipramine

    Monitor Closely (1)terbinafine will increase the level or effect of desipramine by affecting hepatic enzyme CYP2D6 metabolism. Modify Therapy/Monitor Closely. Assess need to reduce dose of CYP2D6-metabolized drug.

  • deutetrabenazine

    Monitor Closely (1)terbinafine will increase the level or effect of deutetrabenazine by affecting hepatic enzyme CYP2D6 metabolism. Modify Therapy/Monitor Closely. Assess need to reduce dose of CYP2D6-metabolized drug.

  • doxepin

    Monitor Closely (1)terbinafine will increase the level or effect of doxepin by affecting hepatic enzyme CYP2D6 metabolism. Modify Therapy/Monitor Closely. Assess need to reduce dose of CYP2D6-metabolized drug.

  • doxepin cream

    Monitor Closely (1)terbinafine will increase the level or effect of doxepin cream by affecting hepatic enzyme CYP2D6 metabolism. Modify Therapy/Monitor Closely. Assess need to reduce dose of CYP2D6-metabolized drug.

  • doxorubicin

    Monitor Closely (1)terbinafine will increase the level or effect of doxorubicin by affecting hepatic enzyme CYP2D6 metabolism. Modify Therapy/Monitor Closely. Assess need to reduce dose of CYP2D6-metabolized drug.

  • doxorubicin liposomal

    Monitor Closely (1)terbinafine will increase the level or effect of doxorubicin liposomal by affecting hepatic enzyme CYP2D6 metabolism. Modify Therapy/Monitor Closely. Assess need to reduce dose of CYP2D6-metabolized drug.

  • duloxetine

    Monitor Closely (2)duloxetine will increase the level or effect of terbinafine by affecting hepatic enzyme CYP1A2 metabolism. Use Caution/Monitor.

    terbinafine will increase the level or effect of duloxetine by affecting hepatic enzyme CYP2D6 metabolism. Modify Therapy/Monitor Closely. Assess need to reduce dose of CYP2D6-metabolized drug.

  • efavirenz

    Monitor Closely (1)efavirenz will decrease the level or effect of terbinafine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.

  • eliglustat

    Monitor Closely (1)terbinafine will increase the level or effect of eliglustat by affecting hepatic enzyme CYP2D6 metabolism. Modify Therapy/Monitor Closely. Assess need to reduce dose of CYP2D6-metabolized drug.

  • elvitegravir/cobicistat/emtricitabine/tenofovir DF

    Monitor Closely (1)elvitegravir/cobicistat/emtricitabine/tenofovir DF will increase the level or effect of terbinafine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.

  • enzalutamide

    Monitor Closely (1)enzalutamide will decrease the level or effect of terbinafine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.

  • etravirine

    Monitor Closely (1)etravirine will decrease the level or effect of terbinafine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.

  • fesoterodine

    Monitor Closely (1)terbinafine will increase the level or effect of fesoterodine by affecting hepatic enzyme CYP2D6 metabolism. Modify Therapy/Monitor Closely. Assess need to reduce dose of CYP2D6-metabolized drug.

  • flecainide

    Monitor Closely (1)terbinafine will increase the level or effect of flecainide by affecting hepatic enzyme CYP2D6 metabolism. Modify Therapy/Monitor Closely. Assess need to reduce dose of CYP2D6-metabolized drug.

  • fluconazole

    Monitor Closely (1)fluconazole will increase the level or effect of terbinafine by affecting hepatic enzyme CYP2C9/10 metabolism. Use Caution/Monitor.

  • fluorouracil

    Monitor Closely (1)fluorouracil will increase the level or effect of terbinafine by affecting hepatic enzyme CYP2C9/10 metabolism. Use Caution/Monitor.

  • fluoxetine

    Monitor Closely (1)terbinafine will increase the level or effect of fluoxetine by affecting hepatic enzyme CYP2D6 metabolism. Modify Therapy/Monitor Closely. Assess need to reduce dose of CYP2D6-metabolized drug.

  • fluphenazine

    Monitor Closely (1)terbinafine will increase the level or effect of fluphenazine by affecting hepatic enzyme CYP2D6 metabolism. Modify Therapy/Monitor Closely. Assess need to reduce dose of CYP2D6-metabolized drug.

  • flurbiprofen

    Monitor Closely (1)flurbiprofen will increase the level or effect of terbinafine by affecting hepatic enzyme CYP2C9/10 metabolism. Use Caution/Monitor.

  • fluvoxamine

    Monitor Closely (2)fluvoxamine will increase the level or effect of terbinafine by affecting hepatic enzyme CYP1A2 metabolism. Use Caution/Monitor.

    terbinafine will increase the level or effect of fluvoxamine by affecting hepatic enzyme CYP2D6 metabolism. Modify Therapy/Monitor Closely. Assess need to reduce dose of CYP2D6-metabolized drug.

  • fosphenytoin

    Monitor Closely (2)fosphenytoin will decrease the level or effect of terbinafine by affecting hepatic enzyme CYP2C9/10 metabolism. Use Caution/Monitor.

    fosphenytoin will decrease the level or effect of terbinafine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.

  • gemfibrozil

    Monitor Closely (1)gemfibrozil will increase the level or effect of terbinafine by affecting hepatic enzyme CYP2C9/10 metabolism. Use Caution/Monitor.

  • grapefruit

    Monitor Closely (1)grapefruit will increase the level or effect of terbinafine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.

  • haloperidol

    Monitor Closely (1)terbinafine will increase the level or effect of haloperidol by affecting hepatic enzyme CYP2D6 metabolism. Modify Therapy/Monitor Closely. Assess need to reduce dose of CYP2D6-metabolized drug.

  • ibuprofen

    Monitor Closely (1)ibuprofen will increase the level or effect of terbinafine by affecting hepatic enzyme CYP2C9/10 metabolism. Use Caution/Monitor.

  • idelalisib

    Monitor Closely (1)idelalisib will increase the level or effect of terbinafine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.

  • iloperidone

    Monitor Closely (1)terbinafine will increase the level or effect of iloperidone by affecting hepatic enzyme CYP2D6 metabolism. Modify Therapy/Monitor Closely. Assess need to reduce dose of CYP2D6-metabolized drug.

  • imipramine

    Monitor Closely (1)terbinafine will increase the level or effect of imipramine by affecting hepatic enzyme CYP2D6 metabolism. Modify Therapy/Monitor Closely. Assess need to reduce dose of CYP2D6-metabolized drug.

  • indinavir

    Monitor Closely (1)indinavir will increase the level or effect of terbinafine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.

  • indomethacin

    Monitor Closely (1)indomethacin will increase the level or effect of terbinafine by affecting hepatic enzyme CYP2C9/10 metabolism. Use Caution/Monitor.

  • isavuconazonium sulfate

    Monitor Closely (1)terbinafine will decrease the level or effect of isavuconazonium sulfate by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.

  • isoniazid

    Monitor Closely (1)isoniazid will increase the level or effect of terbinafine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.

  • itraconazole

    Monitor Closely (1)itraconazole will increase the level or effect of terbinafine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.

  • ivosidenib

    Monitor Closely (2)ivosidenib will decrease the level or effect of terbinafine by affecting hepatic enzyme CYP2C9/10 metabolism. Use Caution/Monitor.

    ivosidenib will decrease the level or effect of terbinafine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.

  • ketoconazole

    Monitor Closely (2)ketoconazole will increase the level or effect of terbinafine by affecting hepatic enzyme CYP2C9/10 metabolism. Use Caution/Monitor.

    ketoconazole will decrease the level or effect of terbinafine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.

  • levofloxacin

    Monitor Closely (1)levofloxacin will increase the level or effect of terbinafine by affecting hepatic enzyme CYP1A2 metabolism. Use Caution/Monitor.

  • lopinavir

    Monitor Closely (1)lopinavir will increase the level or effect of terbinafine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.

  • lorlatinib

    Monitor Closely (1)lorlatinib will decrease the level or effect of terbinafine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.

  • maprotiline

    Monitor Closely (1)terbinafine will increase the level or effect of maprotiline by affecting hepatic enzyme CYP2D6 metabolism. Modify Therapy/Monitor Closely. Assess need to reduce dose of CYP2D6-metabolized drug.

  • mefenamic acid

    Monitor Closely (1)mefenamic acid will increase the level or effect of terbinafine by affecting hepatic enzyme CYP2C9/10 metabolism. Use Caution/Monitor.

  • methamphetamine

    Monitor Closely (1)terbinafine will increase the level or effect of methamphetamine by affecting hepatic enzyme CYP2D6 metabolism. Modify Therapy/Monitor Closely. Assess need to reduce dose of CYP2D6-metabolized drug.

  • methoxsalen

    Monitor Closely (1)methoxsalen will increase the level or effect of terbinafine by affecting hepatic enzyme CYP1A2 metabolism. Use Caution/Monitor.

  • metoclopramide intranasal

    Serious – Use Alternative (1)terbinafine will increase the level or effect of metoclopramide intranasal by affecting hepatic enzyme CYP2D6 metabolism. Avoid or Use Alternate Drug. Concurrent use of metoclopramide intranasal and strong CYP2D6 inhibitors is not recommended since the metoclopramide intranasal dose cannot be adjusted.

  • metoprolol

    Monitor Closely (1)terbinafine will increase the level or effect of metoprolol by affecting hepatic enzyme CYP2D6 metabolism. Modify Therapy/Monitor Closely. Assess need to reduce dose of CYP2D6-metabolized drug.

  • mexiletine

    Monitor Closely (1)mexiletine will increase the level or effect of terbinafine by affecting hepatic enzyme CYP1A2 metabolism. Use Caution/Monitor.

  • mibefradil

    Monitor Closely (1)mibefradil will increase the level or effect of terbinafine by affecting hepatic enzyme CYP1A2 metabolism. Use Caution/Monitor.

  • miconazole oral

    Monitor Closely (1)miconazole oral will increase the level or effect of terbinafine by affecting hepatic enzyme CYP2C9/10 metabolism. Use Caution/Monitor.

  • mifepristone

    Monitor Closely (1)mifepristone will increase the level or effect of terbinafine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.

  • mirtazapine

    Monitor Closely (1)terbinafine will increase the level or effect of mirtazapine by affecting hepatic enzyme CYP2D6 metabolism. Modify Therapy/Monitor Closely. Assess need to reduce dose of CYP2D6-metabolized drug.

  • mitotane

    Monitor Closely (1)mitotane will decrease the level or effect of terbinafine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.

  • nafcillin

    Monitor Closely (1)nafcillin will decrease the level or effect of terbinafine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.

  • nebivolol

    Monitor Closely (1)terbinafine will increase the level or effect of nebivolol by affecting hepatic enzyme CYP2D6 metabolism. Modify Therapy/Monitor Closely. Assess need to reduce dose of CYP2D6-metabolized drug.

  • nefazodone

    Monitor Closely (1)nefazodone will increase the level or effect of terbinafine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.

  • nelfinavir

    Monitor Closely (1)nelfinavir will increase the level or effect of terbinafine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.

  • nicardipine

    Monitor Closely (1)nicardipine will increase the level or effect of terbinafine by affecting hepatic enzyme CYP2C9/10 metabolism. Use Caution/Monitor.

  • norfloxacin

    Monitor Closely (1)norfloxacin will increase the level or effect of terbinafine by affecting hepatic enzyme CYP1A2 metabolism. Use Caution/Monitor.

  • ofloxacin

    Monitor Closely (1)ofloxacin will increase the level or effect of terbinafine by affecting hepatic enzyme CYP1A2 metabolism. Use Caution/Monitor.

  • oliceridine

    Monitor Closely (1)terbinafine will increase the level or effect of oliceridine by affecting hepatic enzyme CYP2D6 metabolism. Modify Therapy/Monitor Closely. If concomitant use is necessary, may require less frequent oliceridine dosing. Closely monitor for respiratory depression and sedation and titrate subsequent doses accordingly. If inhibitor is discontinued, consider increase oliceridine dosage until stable drug effects are achieved. Monitor for signs of opioid withdrawal.

  • paroxetine

    Monitor Closely (1)terbinafine will increase the level or effect of paroxetine by affecting hepatic enzyme CYP2D6 metabolism. Modify Therapy/Monitor Closely. Assess need to reduce dose of CYP2D6-metabolized drug.

  • pentobarbital

    Monitor Closely (1)pentobarbital will decrease the level or effect of terbinafine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.

  • perphenazine

    Monitor Closely (1)terbinafine will increase the level or effect of perphenazine by affecting hepatic enzyme CYP2D6 metabolism. Modify Therapy/Monitor Closely. Assess need to reduce dose of CYP2D6-metabolized drug.

  • phenobarbital

    Monitor Closely (3)phenobarbital will decrease the level or effect of terbinafine by affecting hepatic enzyme CYP1A2 metabolism. Use Caution/Monitor.

    phenobarbital will decrease the level or effect of terbinafine by affecting hepatic enzyme CYP2C9/10 metabolism. Use Caution/Monitor.

    phenobarbital will decrease the level or effect of terbinafine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.

  • phenytoin

    Monitor Closely (2)phenytoin will decrease the level or effect of terbinafine by affecting hepatic enzyme CYP2C9/10 metabolism. Use Caution/Monitor.

    phenytoin will decrease the level or effect of terbinafine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.

  • pimozide

    Monitor Closely (1)terbinafine will increase the level or effect of pimozide by affecting hepatic enzyme CYP2D6 metabolism. Modify Therapy/Monitor Closely. Assess need to reduce dose of CYP2D6-metabolized drug.

  • piroxicam

    Monitor Closely (1)piroxicam will increase the level or effect of terbinafine by affecting hepatic enzyme CYP2C9/10 metabolism. Use Caution/Monitor.

  • pitolisant

    Monitor Closely (1)terbinafine will increase the level or effect of pitolisant by affecting hepatic enzyme CYP2D6 metabolism. Modify Therapy/Monitor Closely. If coadministered with strong CYP2D6 inhibitors, initiate pitolisant at 8.9 mg/day and increase after 7 days to maximum of 17.8 mg/day. For patients currently taking pitolisant, reduce pitolisant dose by half upon initiating strong CYP2D6 inhibitors.

  • posaconazole

    Monitor Closely (1)posaconazole will increase the level or effect of terbinafine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.

  • primaquine

    Monitor Closely (1)primaquine will increase the level or effect of terbinafine by affecting hepatic enzyme CYP1A2 metabolism. Use Caution/Monitor.

  • primidone

    Monitor Closely (3)primidone will decrease the level or effect of terbinafine by affecting hepatic enzyme CYP1A2 metabolism. Use Caution/Monitor.

    primidone will decrease the level or effect of terbinafine by affecting hepatic enzyme CYP2C9/10 metabolism. Use Caution/Monitor.

    primidone will decrease the level or effect of terbinafine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.

  • promethazine

    Monitor Closely (1)terbinafine will increase the level or effect of promethazine by affecting hepatic enzyme CYP2D6 metabolism. Modify Therapy/Monitor Closely. Assess need to reduce dose of CYP2D6-metabolized drug.

  • propafenone

    Monitor Closely (1)terbinafine will increase the level or effect of propafenone by affecting hepatic enzyme CYP2D6 metabolism. Modify Therapy/Monitor Closely. Assess need to reduce dose of CYP2D6-metabolized drug.

  • propranolol

    Monitor Closely (1)terbinafine will increase the level or effect of propranolol by affecting hepatic enzyme CYP2D6 metabolism. Modify Therapy/Monitor Closely. Assess need to reduce dose of CYP2D6-metabolized drug.

  • protriptyline

    Monitor Closely (1)terbinafine will increase the level or effect of protriptyline by affecting hepatic enzyme CYP2D6 metabolism. Modify Therapy/Monitor Closely. Assess need to reduce dose of CYP2D6-metabolized drug.

  • rifabutin

    Monitor Closely (1)rifabutin will decrease the level or effect of terbinafine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.

  • rifampin

    Monitor Closely (2)rifampin will decrease the level or effect of terbinafine by affecting hepatic enzyme CYP1A2 metabolism. Use Caution/Monitor.

    rifampin will decrease the level or effect of terbinafine by affecting hepatic enzyme CYP2C9/10 metabolism. Use Caution/Monitor.

  • rifapentine

    Monitor Closely (2)rifapentine will decrease the level or effect of terbinafine by affecting hepatic enzyme CYP2C9/10 metabolism. Use Caution/Monitor.

    rifapentine will decrease the level or effect of terbinafine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.

  • risperidone

    Monitor Closely (1)terbinafine will increase the level or effect of risperidone by affecting hepatic enzyme CYP2D6 metabolism. Modify Therapy/Monitor Closely. Assess need to reduce dose of CYP2D6-metabolized drug.

  • ritonavir

    Monitor Closely (2)ritonavir will increase the level or effect of terbinafine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.

    terbinafine will increase the level or effect of ritonavir by affecting hepatic enzyme CYP2D6 metabolism. Modify Therapy/Monitor Closely. Assess need to reduce dose of CYP2D6-metabolized drug.

  • rucaparib

    Monitor Closely (3)rucaparib will increase the level or effect of terbinafine by affecting hepatic enzyme CYP1A2 metabolism. Use Caution/Monitor.

    rucaparib will increase the level or effect of terbinafine by affecting hepatic enzyme CYP2C9/10 metabolism. Use Caution/Monitor.

    rucaparib will increase the level or effect of terbinafine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.

  • Saccharomyces boulardii

    Serious – Use Alternative (1)terbinafine decreases effects of Saccharomyces boulardii by unspecified interaction mechanism. Avoid or Use Alternate Drug. Systemic or oral antifungals may decrease activity of probiotic.

  • saquinavir

    Monitor Closely (1)saquinavir will increase the level or effect of terbinafine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.

  • secobarbital

    Monitor Closely (2)secobarbital will decrease the level or effect of terbinafine by affecting hepatic enzyme CYP2C9/10 metabolism. Use Caution/Monitor.

    secobarbital will decrease the level or effect of terbinafine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.

  • sertraline

    Monitor Closely (1)terbinafine will increase the level or effect of sertraline by affecting hepatic enzyme CYP2D6 metabolism. Modify Therapy/Monitor Closely. Assess need to reduce dose of CYP2D6-metabolized drug.

  • St John’s Wort

    Monitor Closely (1)St John’s Wort will decrease the level or effect of terbinafine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.

  • stiripentol

    Monitor Closely (1)stiripentol will increase the level or effect of terbinafine by Other (see comment). Use Caution/Monitor. Stiripentol (CYP1A2/CYP3A4 inducer and inhibitor) may increase or decrease terbinafine (CYP1A2/CYP3A4 substrate) levels.

  • sulfadiazine

    Monitor Closely (1)sulfadiazine will increase the level or effect of terbinafine by affecting hepatic enzyme CYP2C9/10 metabolism. Use Caution/Monitor.

  • sulfamethoxazole

    Monitor Closely (1)sulfamethoxazole will increase the level or effect of terbinafine by affecting hepatic enzyme CYP2C9/10 metabolism. Use Caution/Monitor.

  • tacrine

    Monitor Closely (1)tacrine will increase the level or effect of terbinafine by affecting hepatic enzyme CYP1A2 metabolism. Use Caution/Monitor.

  • tamoxifen

    Monitor Closely (1)terbinafine will increase the level or effect of tamoxifen by affecting hepatic enzyme CYP2D6 metabolism. Modify Therapy/Monitor Closely. Assess need to reduce dose of CYP2D6-metabolized drug.

  • tamsulosin

    Monitor Closely (1)terbinafine will increase the level or effect of tamsulosin by affecting hepatic enzyme CYP2D6 metabolism. Modify Therapy/Monitor Closely. Assess need to reduce dose of CYP2D6-metabolized drug.

  • tazemetostat

    Monitor Closely (1)terbinafine will decrease the level or effect of tazemetostat by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.

  • thioridazine

    Monitor Closely (1)terbinafine will increase the level or effect of thioridazine by affecting hepatic enzyme CYP2D6 metabolism. Modify Therapy/Monitor Closely. Assess need to reduce dose of CYP2D6-metabolized drug.

  • timolol

    Monitor Closely (1)terbinafine will increase the level or effect of timolol by affecting hepatic enzyme CYP2D6 metabolism. Modify Therapy/Monitor Closely. Assess need to reduce dose of CYP2D6-metabolized drug.

  • timolol ophthalmic

    Monitor Closely (1)terbinafine will increase the level or effect of timolol ophthalmic by affecting hepatic enzyme CYP2D6 metabolism. Modify Therapy/Monitor Closely. Assess need to reduce dose of CYP2D6-metabolized drug.

  • tipranavir

    Monitor Closely (1)tipranavir will increase the level or effect of terbinafine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.

  • tolbutamide

    Monitor Closely (1)tolbutamide will increase the level or effect of terbinafine by affecting hepatic enzyme CYP2C9/10 metabolism. Use Caution/Monitor.

  • tolterodine

    Monitor Closely (1)terbinafine will increase the level or effect of tolterodine by affecting hepatic enzyme CYP2D6 metabolism. Modify Therapy/Monitor Closely. Assess need to reduce dose of CYP2D6-metabolized drug.

  • tramadol

    Monitor Closely (1)terbinafine will increase the level or effect of tramadol by affecting hepatic enzyme CYP2D6 metabolism. Modify Therapy/Monitor Closely. Assess need to reduce dose of CYP2D6-metabolized drug.

  • trimipramine

    Monitor Closely (1)terbinafine will increase the level or effect of trimipramine by affecting hepatic enzyme CYP2D6 metabolism. Modify Therapy/Monitor Closely. Assess need to reduce dose of CYP2D6-metabolized drug.

  • ubrogepant

    Monitor Closely (1)terbinafine will decrease the level or effect of ubrogepant by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Monitor Closely. Dose adjustment is recommended with concomitant use of ubrogepant and moderate and weak CYP3A4 inducers. (see Dosage Modifications)

  • valbenazine

    Monitor Closely (1)terbinafine will increase the level or effect of valbenazine by affecting hepatic enzyme CYP2D6 metabolism. Modify Therapy/Monitor Closely. Assess need to reduce dose of CYP2D6-metabolized drug.

  • venlafaxine

    Monitor Closely (1)terbinafine will increase the level or effect of venlafaxine by affecting hepatic enzyme CYP2D6 metabolism. Modify Therapy/Monitor Closely. Assess need to reduce dose of CYP2D6-metabolized drug.

  • voclosporin

    Monitor Closely (1)voclosporin, terbinafine.
    Either increases toxicity of the other by nephrotoxicity and/or ototoxicity. Modify Therapy/Monitor Closely. Coadministration with drugs associated with nephrotoxicity may increase the risk for acute and/or chronic nephrotoxicity.

  • voriconazole

    Monitor Closely (2)voriconazole will increase the level or effect of terbinafine by affecting hepatic enzyme CYP2C9/10 metabolism. Use Caution/Monitor.

    voriconazole will increase the level or effect of terbinafine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.

  • vortioxetine

    Monitor Closely (1)terbinafine will increase the level or effect of vortioxetine by affecting hepatic enzyme CYP2D6 metabolism. Modify Therapy/Monitor Closely. Assess need to reduce dose of CYP2D6-metabolized drug.

  • zileuton

    Monitor Closely (1)zileuton will increase the level or effect of terbinafine by affecting hepatic enzyme CYP1A2 metabolism. Use Caution/Monitor.

  • Fungus

    It is in the spring that outbreaks of various fungal diseases occur. And it is not surprising, because at this time, almost all people have a decrease in the protective properties of the body. And fungi, according to dermatologists, are present on the skin and mucous membranes of every person.
    In addition to weakening the immune system, doctors also include standing work, infected shoes, vascular diseases, varicose veins, cuts and wounds as risk factors.
    Modern medicine can offer a huge and effective arsenal of antifungal agents for external use.When prescribing an antifungal drug, the doctor will take into account not only its effectiveness and safety, but also the spread of the focus of the disease. For the treatment of fungal diseases, a number of drugs are used that differ in their mechanism and spectrum of action, origin (synthetic or natural), antifungal effect (fungistatic or fungicidal), methods of administration (externally, internally), indications for use (systemic or local infections). Medicines for nail fungus come in the form of oral preparations – capsules and tablets, and local forms – varnishes, sprays.
    Exoderil is available in the form of a cream and solution for external use. It should be noted that “Exoderil” is characterized by a wide spectrum of antifungal action, exhibits pronounced anti-inflammatory properties. A variety of dosage forms allows for high-quality external antifungal therapy. Exoderil has a number of advantages: a wide range of antifungal activity; a combination of antibacterial and anti-inflammatory properties; optimal ratio of efficiency and safety; effective penetration of the active substance into all affected skin areas; ease of use (only 1 time per day).
    “Lamisil” offers a wide range of forms for quick and effective treatment of fungus: “Lamisil” cream – softens dry and rough skin with fungus of feet and hands; “Lamisil Dermgel” – cools, relieves itching, dries the skin and is quickly absorbed; “Lamisil Uno” is a unique remedy for treating foot fungus in just one application; “Lamisil Spray” is the optimal form for active people, it is well absorbed, it is convenient for treating fungus of hairy areas and large skin folds.
    Lotseril is an antifungal varnish.It is used for the prevention and treatment of fungal diseases of the nail plate. This antifungal drug is produced in France, a set of tampons, spatulas and nail files is attached to the varnish. The active substance of “Lotseril” penetrates the cells of the pathogen and destroys them. The varnish affects not only the nail itself, but also the soft tissues located directly under it.
    Batrafen nail varnish – a number of properties bring this dosage form closer to the optimal one for local treatment of mycoses: high concentration of the active substance and its optimal release; good penetration through the nail tissue and the ability to accumulate in it; stable fixation of the remedy on the nail plate; high antifungal effectiveness; simplicity and ease of use.
    The Mikospor set is convenient for treating nails – it contains an adhesive plaster, a scraper and an ointment containing bifonazole, urea, lanolin and petroleum jelly.
    “FUNDIZOL” cream is an effective remedy for the treatment of fungal infections of nails, fungal and bacterial skin lesions, “ingrown nails”. Fundizol softens and removes the damaged part of the nail plate and the superficial affected layer of the epidermis damaged by the fungus. Softens the skin of the feet, heals skin cracks. Eliminates unpleasant foot odor.Painlessly removes the part of the nail affected by the fungus.
    Antifungal socks and insoles can be used to prevent fungal infections. Antifungal socks will reliably protect nails, toes and feet from fungal and pustular diseases, can reduce unpleasant odor of sweat from feet, and provide a high level of comfort, especially when wearing thick, non-breathable shoes for a long time. Antifungal insoles: their main purpose is to protect the feet from the growth of bacteria inside the shoe, to eliminate high humidity.
    Number of impressions: 6822
    90,000 Lamisil. Ointment for nail fungus, analogs in tablets

    In most cases, a fungal infection affects an organism with a weakened immune system, and the skin and nails are most vulnerable to the external effects of pathogenic microorganisms. If the color of the nail begins to change, the structure of the nail plate is disrupted, and the skin on the finger becomes inflamed, then be sure to consult a dermatologist to identify the cause of the pathological process. Onychomycosis is a dangerous disease and the activity of nail fungus at the last stage of the infectious process can lead to the penetration of dermatophytes to the internal organs through the blood.

    Antimycotic agent Lamisil blocks the activity and reproduction of fungal infection. The doctor prescribes a treatment course and regular use of Lamisil gradually leads to the destruction of dermatophytes and their spores. For the treatment of onychomycosis, tablets, ointment (cream), spray, varnish with the name ‘Lamisil’ are used, but the main active ingredient of the drug is terbinafine. Terbinafine belongs to a broad spectrum of substances and successfully suppresses the activity of not only nail fungi, but also other pathogenic microorganisms that cause various mycoses and candidiasis.

    The substance blocks the exchange of proteins in the cells of the fungus and causes a violation of the synthesis of sterols, after which these microorganisms quickly die. Before using Lamisil, carefully read the instructions for use of the product and follow the doctor’s instructions every day, observing the treatment regimen for onychomycosis. You can supplement the main course of treatment of a fungal disease with effective folk remedies. For example, before using the medication, soak your feet with baking soda and tea tree essential oil, and then wipe your toes with hydrogen peroxide solution.

    ► Any medicines for internal or external use can be used ONLY after consulting a doctor!

    ♦ LAMISIL TABLETS

    Dose:
    Adults: 250 mg (1 tablet) once a day.
    The dosage for children depends on their body weight:
    – More than 40 kg: 1 tablet per day.
    – 20-40 kg: 125 mg (1/2 tablet) per day.
    – Less than 20 kg: 62.5 mg (1/4 tablet) per day.
    – Children under 2 years old should not use Lamisil tablets.

    Analogues of medicines are cheaper:
    Terbinafine, Thermikon, Fungoterbin, Exifin, Binafin.

    – Lamisil tablets. Complete instructions for use of the product

    ♦ OINTMENT (CREAM) ‘LAMISIL’

    Application:
    – For adults and children over 12 years old, the cream can be applied 1 or 2 times a day, depending on the stage of mycosis.
    – The use of the cream is not prescribed for children under 12 years of age.

    Analogues of the product are cheaper:

    Terbinafin, Thermikon, Fungoterbin, Exifin, Binafin, Atifin, Exoderil, Batrafen, Mikoseptin.

    – Lamisil Ointment. Complete instructions for use of the product

    ♦ LAMISIL SPRAY

    Application:

    – Adults can use the spray 1 or 2 times a day, depending on the indication. Before applying the product, the affected areas must be thoroughly cleaned and dried.
    – Spray is not prescribed for children under 18 years of age.

    Analogs of the product are cheaper:

    Thermikon, Fungoterbin.

    – Spray Lamisil. Complete instructions for use of the product

    ♦ LAMISIL LACQUER

    Application:
    – Use the varnish twice a week until the symptoms of fungal infection are completely eliminated. It is applied to the affected nails and to the surface of healthy nail plates to prevent the spread of fungal spores on them.
    – Children under 12 years old are not prescribed varnish.

    Analogs of the product are cheaper (without the substance terbinafine):
    Demikten, Mikosan, Oflomil, Amoderm Neolak, Amorolac 5%, Exoderil.

    – Lamisil varnish. Complete instructions for using the tool


    ♦ VIDEO MATERIALS

    Your recommendations will be very useful to all visitors of the site! Please leave comments on the article, share with each other the secrets of home nail care, tips for the prevention of diseases of the nail plates.
    If you want to place your photo and video materials on the topic on the site, please write a message to us by email:
    This e-mail address is being protected from spambots.You need JavaScript enabled to view it

    Go to main page

    ALSO FIND OUT …


    Similar Materials:

    Next Materials:

    Previous Materials:


    nail fungus lamisil treatment reviews

    nail fungus lamisil treatment reviews

    nail fungus lamisil treatment responses

    >>> GO TO OFFICIAL SITE >>>

    What is lamisil nail fungus treatment reviews?

    The wide spectrum of activity of the cream against the fungus Remitazol makes it the most effective in the treatment of onychomycosis and skin lesions at any stage.Even in advanced cases, it allows you to do without systemic therapy, reduces the risks for the liver, gastrointestinal tract and neutralizes the drug load on the body.

    The effect of the use of nail fungus lamisil treatment responses

    Remitazol cream can be used at any stage of the disease – from distal to total lesion. The intensely absorbed product is able to penetrate into the deeper layers of the dermis and under the nail, stopping the spread of infection and the multiplication of spores.

    Expert opinion

    The natural composition of the cream against the fungus Remitazol allows its use in long courses against all types of mycoses.

    How to order

    In order to place an order for nail fungus lamisil treatment reviews, you must leave your contact information on the site. The operator will contact you within 15 minutes. Will clarify all the details with you and we will send your order. In 3-10 days you will receive the parcel and pay for it upon receipt.

    Customer Reviews:

    Julia

    Remitazol is a preparation based on herbal and plant extracts, it works flawlessly even in the most advanced cases. Today, all people can get sick with a fungus, regardless of age. Any contact with dirty flooring can lead to infection.

    Masha

    Is Remitazole a dummy? Probably the one who says this has simply never used it.For me, the cream really worked. Give odds to any drug – cured my cracked feet

    Have you noticed the appearance of peeling, darkening and itching on the skin and horns of the feet, or perhaps you are unsuccessfully fighting the unpleasant odor emanating from them? Such symptoms are characteristic of a fungal infection, which makes the life of an active person a nightmare. Fungus is not only an aesthetic defect, but also a serious symptom complex, inattention to which is fraught with the appearance of various types of allergies, severe lesions of internal organs and even amputation of the affected limbs.Are you afraid of such consequences? In this case, do not hesitate to treat mycosis by choosing Remitazol cream as a therapy. Where to buy lamisil nail fungus treatment reviews? The natural composition of the cream from the fungus Remitazol (Remitazol) allows you to use it for long courses against any type of mycoses.

    Nail fungus (mycosis and onychomycosis) is a destructive change in the appearance and structure of the nail plate, sometimes with a transition to the skin of the legs. The reason for this phenomenon is always more than 10 types of dermatophytes, yeast-like (candida) and molds.To select one of those presented in. There will not even be positive reviews for any broad-spectrum antifungal drug. Broad-spectrum external preparations against nail fungus. … Treatment – external formulations together with tablets of antimycotic activity. Cream lamisil (novartis) was prescribed by a dermatologist a few years ago to my husband for the treatment of foot fungus. … Lamisil, like Exoderil, is an imported antifungal agent. Fungal infection of nails, feet, toes is one of the most unpleasant diseases.Refers to infectious. Antifungal agent Novartis Lamisil Cream – reviews. The average . I picked up the fungus in the sauna after the gym, without consulting I bought lamisil, it seemed like a good advertisement and it was said that from all types of fungus, I began to smear in the evenings, the foot began to burn and turn red, I thought such an effect, it was not there. ✍🏼Reviews of those who took the drug Lamisil, read the current reviews and order Lamisil at low prices on Uteka. … Toenail fungus has been following me for three years.In my small town, I went around many doctors, the same ointments were prescribed, which they did not give. Treatment with antifungal medications is worth completing if the nails begin to flake off. Reviews of antifungal varnishes. Nail fungus is an onychomycosis caused by mycelium as a result of penetration deep into the plates and even the body. Nail fungus. Olga, Rostov-on-Don. … Olga, from the photo it is a fungus. But if you start treatment now, before the analysis, then the analysis will then be uninformative. … 1989-1996 Perm State Medical University.Work experience: 24 years. 95 reviews. Mikhail Matveev. Dermatologist, Venereologist. 1991-1997 IvGMA. Reviews of Lamisil from visitors ✅ instructions for use Lamisil ✅. The nails began to grow normal, the spots on the skin stopped forming. … I found a fungus and to get rid of it I did not take independent measures, but turned to the doctor. The specialist recommended it to me. Lamisil: 7 reviews from doctors, 9 reviews from patients, instructions for use. The average duration of treatment and the frequency of use of the drug at.My husband suffered from toenail fungus for over 10 years. Nothing helped. Having dropped his hands, he stopped treating the fungus in recent years. We have selected real reviews of Lamisil, which are published by our users. Most often, the review is written by the mothers of young patients, but they also describe the personal history of using the medicine on themselves. Discussion of the drug Lamisil in the notes of mothers. ♥. 03/15/2008. I have.

    https://www.antiaging.org.tr/dosyalar/lechenie_gribka_nogtei_kazan_otzyvy9892.xml

    https://www.meduzaingatlan.hu/userfiles/gribok_v_pakhu_lechenie_narodnymi_sredstvami2513.xml

    http://www.viadagio.be/userfiles/lechenie_gribka_voronezh4816.xml

    http://www.condocashback.ca/images/dermatolog_gribok_nogtia_lechenie1669.xml

    http://www.communeouchamps.fr/userfiles/lechenie_gribka_kirov2733.xml

    Remitazol cream can be used at any stage of the disease – from distal to total lesion. The intensely absorbed product is able to penetrate into the deeper layers of the dermis and under the nail, stopping the spread of infection and the multiplication of spores.
    nail fungus lamisil treatment reviews

    The wide spectrum of activity of the cream from the fungus Remitazol makes it the most effective in the treatment of onychomycosis and skin lesions at any stage. Even in advanced cases, it allows you to do without systemic therapy, reduces the risks for the liver, gastrointestinal tract and neutralizes the drug load on the body.

    For the treatment of nail fungus, tablets are combined with local forms of drugs.The course of treatment is 150 mg per day for. The drug is taken when local treatment is ineffective or the fungus is resistant to other agents. Suppresses the activity of opportunistic flora, which is important when. What is nail fungus and where does it come from? What pills help in the fight against fungus. … Nail fungus is not only an unpleasant problem, but also ugly. With nails affected by fungus, it is a shame to appear on the beach, it is impossible to wear elegant shoes, you cannot go to the pool. For a successful fight against.Preparations from the fungus for external use. Creamy remedies against nail fungus. Nail fungus varnishes. Sprays and solutions for the treatment of fungus and disinfection. Pills against nail fungus. Release form: Tablets of 250 mg. Pack of 28 tablets. Contraindications … When treating with terbinafine, general hygiene rules should be followed to prevent the possibility of re-infection through. Nail fungus. Broad-spectrum external preparations against nail fungus. … The most toxic drugs for the treatment of deep lesions are sold only by.Treatment – external formulations together with tablets of antimycotic activity. ANTIFUNGAL DRUGS. Fungus Treatment – Creams / Ointments. … If mycosis of nails has already passed into an advanced stage, and previously used. Under the influence of local agents, only those microorganisms that come into contact with the nail plate itself (or with the surrounding skin) die. For the treatment of nail fungus, they use: creams, ointments, tablets, solutions, sprays, varnishes and natural remedies. Often, complex treatment includes the use of several types of funds at the same time.* The price for goods in the category of Tablets for the treatment of fungus in Moscow is indicated without discounts and delivery costs. … According to presidential decree No. 187 of March 17, 2020 on the remote sale of non-prescription drugs, home delivery of non-prescription drugs is carried out, as well.